Poongodhai Ramachandran
Cardiovascular Disease · Texarkana, TXNPI 1265489348
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,871 of the $3,385 with a category attached, or 84.8%. It is spread thinly across 20 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,261 and has fallen 56.3% since, to $552 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in TX, where the typical reported total is $3,258.
Across 183 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$643
- Baxter Healthcare$506
- Novartis$446
- Amgen$373
- Boehringer Ingelheim$281
- AstraZeneca$235
- plus $902 from 14 others
What the payments were for
- Food & beverage$2,87185%
- Education$80%
- Other$50615%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 40 | $643 |
| Baxter Healthcare | 1 | $506 |
| Novartis | 34 | $446 |
| Amgen | 20 | $373 |
| Boehringer Ingelheim | 17 | $281 |
| AstraZeneca | 14 | $235 |
| Pfizer | 13 | $235 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $234 |
| Amarin Pharma, Inc. | 8 | $124 |
| Boston Scientific | 3 | $39 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Biotronik Inc. | 1 | $36 |
| Alnylam Pharmaceuticals Inc. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Merck | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| Abbott | 1 | $18 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Elutia, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$121
How this compares
$3,385 in reported general payments places this provider in the 50th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Texarkana
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
- Robert SalazarKingwood$478K
- Reynolds DelgadoHouston$471K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.